Sanofi (SNYNF) Equity Average (2018)

Sanofi (SNYNF) posted Equity Average of $70.0 billion for Q1 2018.

Sanofi (SNYNF) Equity Average (2018) Analysis & Trends

Sanofi (SNYNF) has 1 years of Equity Average data on file, last reported at $70.0 billion in Q1 2018.

Quarterly Equity Average changed N/A year-over-year to $70.0 billion in Q1 2018, while the trailing twelve-month figure through Mar 2018 was $70.0 billion (changed N/A YoY) and the FY2025 annual result came in at $83.0 billion, up 1.84% from the prior year.
Equity Average steadied at $70.0 billion in Q1 2018 per SNYNF's latest filing.
The five-year high for Equity Average was $70.0 billion in Q1 2018, with the low at $70.0 billion in Q1 2018.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Equity Avg. (Qtr)
1	Eli Lilly	1,066.16 Bn	1,060.88 Bn	16.22 Bn	28.87 Bn
2	Johnson & Johnson	611.69 Bn	589.64 Bn	15.96 Bn	81.37 Bn
3	AbbVie	444.34 Bn	434.99 Bn	10.78 Bn	-4.96 Bn
4	Astrazeneca	284.94 Bn	277.05 Bn	12.61 Bn	-
5	Merck	224.23 Bn	218.58 Bn	12.09 Bn	49.27 Bn
6	Amgen	195.12 Bn	183.08 Bn	5.87 Bn	8.92 Bn
7	Gilead Sciences	156.45 Bn	148.73 Bn	5.52 Bn	23.11 Bn
8	Pfizer	136.01 Bn	123.24 Bn	-1.21 Bn	88.29 Bn
9	Novartis Ag	113.45 Bn	113.67 Bn	-	-
10	Sanofi	-	-	9.49 Bn	-

Historic Data

Download Data

Date	Value
Mar 31, 2018	69.97 Bn